
Global Newborn and Prenatal Genetic Testing Market Growth (Status and Outlook) 2025-2031
Description
According to this study, the global Newborn and Prenatal Genetic Testing market size will reach US$ million by 2031.
Newborn and prenatal genetic testing is to judge the underlying genetic disease of the newborn and fetus.
Due to the increased prevalence of genetic diseases and chromosomal abnormalities, the need for early screening for prenatal and newborn defects has increased. According to the Centers for Disease Control and Prevention (CDC), birth defects occur in about 3% of the total number of live births worldwide, leading to infant death.
LPI (LP Information)' newest research report, the “Newborn and Prenatal Genetic Testing Industry Forecast” looks at past sales and reviews total world Newborn and Prenatal Genetic Testing sales in 2024, providing a comprehensive analysis by region and market sector of projected Newborn and Prenatal Genetic Testing sales for 2025 through 2031. With Newborn and Prenatal Genetic Testing sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Newborn and Prenatal Genetic Testing industry.
This Insight Report provides a comprehensive analysis of the global Newborn and Prenatal Genetic Testing landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Newborn and Prenatal Genetic Testing portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Newborn and Prenatal Genetic Testing market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Newborn and Prenatal Genetic Testing and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Newborn and Prenatal Genetic Testing.
This report presents a comprehensive overview, market shares, and growth opportunities of Newborn and Prenatal Genetic Testing market by product type, application, key players and key regions and countries.
Segmentation by Type:
PCR
FISH
aCGH
NIPT
MSS
Segmentation by Application:
Hospital
Clinic
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Perkin Elmer
Verinata Health
Sequenom, Inc.
Agilent Technologies, Inc.
Bio-Rad Laboratories, Inc.
Natera, Inc.
Illumina, Inc.
Ariosa Diagnostics
BGI
CapitalBio MedLab
Please note: The report will take approximately 2 business days to prepare and deliver.
Newborn and prenatal genetic testing is to judge the underlying genetic disease of the newborn and fetus.
Due to the increased prevalence of genetic diseases and chromosomal abnormalities, the need for early screening for prenatal and newborn defects has increased. According to the Centers for Disease Control and Prevention (CDC), birth defects occur in about 3% of the total number of live births worldwide, leading to infant death.
LPI (LP Information)' newest research report, the “Newborn and Prenatal Genetic Testing Industry Forecast” looks at past sales and reviews total world Newborn and Prenatal Genetic Testing sales in 2024, providing a comprehensive analysis by region and market sector of projected Newborn and Prenatal Genetic Testing sales for 2025 through 2031. With Newborn and Prenatal Genetic Testing sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Newborn and Prenatal Genetic Testing industry.
This Insight Report provides a comprehensive analysis of the global Newborn and Prenatal Genetic Testing landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Newborn and Prenatal Genetic Testing portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Newborn and Prenatal Genetic Testing market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Newborn and Prenatal Genetic Testing and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Newborn and Prenatal Genetic Testing.
This report presents a comprehensive overview, market shares, and growth opportunities of Newborn and Prenatal Genetic Testing market by product type, application, key players and key regions and countries.
Segmentation by Type:
PCR
FISH
aCGH
NIPT
MSS
Segmentation by Application:
Hospital
Clinic
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Perkin Elmer
Verinata Health
Sequenom, Inc.
Agilent Technologies, Inc.
Bio-Rad Laboratories, Inc.
Natera, Inc.
Illumina, Inc.
Ariosa Diagnostics
BGI
CapitalBio MedLab
Please note: The report will take approximately 2 business days to prepare and deliver.
Table of Contents
84 Pages
- *This is a tentative TOC and the final deliverable is subject to change.*
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.